Checchi Capital Advisers LLC raised its position in Aflac Incorporated (NYSE:AFL – Free Report) by 1.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 7,080 shares of the financial services provider’s stock after acquiring an additional 115 shares during the period. Checchi Capital Advisers LLC’s holdings in Aflac were worth $732,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in AFL. Darwin Wealth Management LLC acquired a new stake in shares of Aflac in the third quarter valued at about $34,000. BankPlus Trust Department acquired a new stake in shares of Aflac in the fourth quarter valued at about $34,000. Raelipskie Partnership acquired a new stake in shares of Aflac in the third quarter valued at about $38,000. Covestor Ltd lifted its stake in shares of Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after purchasing an additional 107 shares during the period. Finally, Kennebec Savings Bank acquired a new stake in shares of Aflac in the third quarter valued at about $45,000. Institutional investors and hedge funds own 67.44% of the company’s stock.
Insider Activity at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.80% of the stock is owned by insiders.
Aflac Stock Performance
Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, equities analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be issued a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a yield of 2.19%. This is an increase from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Wednesday, February 19th. Aflac’s payout ratio is presently 24.17%.
Analyst Ratings Changes
Several analysts recently commented on the stock. Wells Fargo & Company reduced their price objective on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Barclays reduced their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, February 7th. Evercore ISI dropped their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. Finally, BMO Capital Markets initiated coverage on shares of Aflac in a report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 target price for the company. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $102.86.
View Our Latest Research Report on AFL
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- Why Invest in High-Yield Dividend Stocks?
- Buffett’s on the Sidelines – Should You Follow?
- When to Sell a Stock for Profit or Loss
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Stock Sentiment Analysis: How it Works
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.